FSD Pharma Announces Launch of New Corporate Website
January 20, 2022
Ryan Allway January 20th, 2022 News, Psychedelics New Website Shares FSD’s Unique Drug Pipeline and Vision to Improve the Quality of Life for Patients Suffering from Brain & Inflammatory Disorders TORONTO, January 20, 2022–(BUSINESS WIRE)–FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“FSD Pharma” or the “Company“), a... Read more
Evogene Reports First Quarter 2021 Financial Results
May 26, 2021
Ryan Allway May 26th, 2021 REHOVOT, Israel, May 26, 2021 /PRNewswire/ — Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutionize life-science product discovery and development across several market segments, announces today its financial results for the first quarter of 2021. Mr. Ofer Haviv, Evogene’s President and CEO, stated, “A... Read more
Former GW Pharmaceuticals CFO joins Beckley Psytech’s Board
April 13, 2021
Ryan Allway April 13th, 2021 Psychedelics Beckley Psytech, a private company dedicated to addressing neurological and psychiatric disorders through psychedelic medicine, has appointed ex-GW Pharmaceuticals CFO Adam George as a director with immediate effect. Bringing nearly two decades of experience in the pharmaceuticals industry, Adam served as Chief Financial... Read more
